FDA Investigator: Brentley S. Collins

- Brentley S. Collins first started conducting FDA inspections in 2014, with the last inspection in 2024. Over that time, Brentley S. Collins has conducted 148 inspections at 130 companies across 142 sites.

Documents

FDA 483 MedImmune U.K. Limited, Liverpool | 2024

Out-of-stock
Brentley S. Collins
Biologics Form 483

FDA 483 Valneva Scotland Ltd., Livingston | 2024

Out-of-stock
Brentley S. Collins
Biologics Form 483

FDA 483 Corixa Corporation, Marietta | 2024

Out-of-stock
Brentley S. Collins
Biologics Form 483

FDA 483 Spark Therapeutics, Inc., Philadelphia | 2022

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Cord for Life, Inc., Altamonte Springs | 2021

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Merck Sharp & Dohme Corp., West Point | 2021

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Yado Medical Inc, Columbia | 2020

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Vitrologic, Inc., dba Specialty Sera, Charleston | 2019

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC, Sanford | 2019

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 Rowny Systems, Inc., Cabin John | 2019

Out-of-stock
Brentley S. Collins
Biologic Form 483

FDA 483 UCLA Health Systems, Blood & Platelet Center, Los Angeles | 2019

Out-of-stock
Brentley S. Collins
Biologic Form 483

Co-Investigators (50)